EU

Consent — and the right to withdraw it — underlies the EU's newly effective General Data Protection Regulation for researchers in Europe and beyond.

The VISAGE consortium's efforts coincide with a push in Germany to allow DNA phenotyping and biogeographical ancestry testing in criminal investigations.

The change will be felt most immediately in Europe, where the Dutch molecular diagnostics company recently secured a CE-IVD mark for its MammaPrint BluePrint kit.

Edited Not Modified

A European Union lawyer argues that gene-edited crops should be exempt from genetically modified organism laws in the EU, the Guardian reports.

Over the next three years, the company and its partners will assess the OneRNA platform to diagnose bladder cancer, select treatment, and measure response and recurrence.

Stay a Spell

The European Union and the UK have developed an agreement that would enable EU researchers to stay in the UK post-Brexit, Science reports.

The new European initiative promises to deliver multiple new tests and methods for improving the treatment of breast cancer and rectal cancer.

The firm will launch two new analysis modules for its Genetic Information Management Suite next year, in addition to a new pharmacogenomics mobile application.

'Could Lose Our Edge'

A new report suggests the UK's stature in science and research could fall post-Brexit, the Guardian reports.

Areas of concern are the recruitment of talented scientists, as well as retaining access to EU funding, European research collaborations, and clinical trials.

Pages

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.